DE2460537C2 - - Google Patents

Info

Publication number
DE2460537C2
DE2460537C2 DE2460537A DE2460537A DE2460537C2 DE 2460537 C2 DE2460537 C2 DE 2460537C2 DE 2460537 A DE2460537 A DE 2460537A DE 2460537 A DE2460537 A DE 2460537A DE 2460537 C2 DE2460537 C2 DE 2460537C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2460537A
Other languages
German (de)
Other versions
DE2460537A1 (de
Inventor
Janice Harrow Middlesex Gb Bradshaw
Martin Christopher Liverpool Gb Cook
Gordon Ian Gregory
John Derek Chalfont St. Peter Buckinghamshire Gb Cocker
Derek Ronald Harrow Middlesex Gb Sutherland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE2460537A1 publication Critical patent/DE2460537A1/de
Application granted granted Critical
Publication of DE2460537C2 publication Critical patent/DE2460537C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19742460537 1973-12-21 1974-12-20 Cephalosporin-antibiotika Granted DE2460537A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (2)

Publication Number Publication Date
DE2460537A1 DE2460537A1 (de) 1975-07-03
DE2460537C2 true DE2460537C2 (fr) 1987-01-22

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742460537 Granted DE2460537A1 (de) 1973-12-21 1974-12-20 Cephalosporin-antibiotika

Country Status (15)

Country Link
JP (1) JPS5844675B2 (fr)
AT (1) AT344888B (fr)
CH (1) CH617703A5 (fr)
DE (1) DE2460537A1 (fr)
DK (1) DK674674A (fr)
ES (2) ES433226A1 (fr)
FI (1) FI65258C (fr)
FR (1) FR2255076B1 (fr)
HU (1) HU172234B (fr)
IE (1) IE42144B1 (fr)
IL (1) IL46302A (fr)
LU (1) LU71550A1 (fr)
NL (1) NL7416665A (fr)
NO (1) NO744621L (fr)
SE (1) SE7416195L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019462A1 (de) * 1979-05-23 1980-12-04 Rhone Poulenc Ind Neue 3-vinyl-cephalosporin-derivate und verfahren zu deren herstellung

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4144393A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (fr) * 1976-02-16 1981-01-13 Michael Gregson Traduction non-disponible
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
ES485439A1 (es) * 1978-10-27 1980-07-01 Glaxo Group Ltd Un procedimiento para la preparacion de antibioticos de ce- falosporina
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019462A1 (de) * 1979-05-23 1980-12-04 Rhone Poulenc Ind Neue 3-vinyl-cephalosporin-derivate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
AT344888B (de) 1978-08-10
IL46302A0 (en) 1975-03-13
ATA1020174A (de) 1977-12-15
FR2255076B1 (fr) 1978-11-10
ES433226A1 (es) 1977-07-01
NL7416665A (nl) 1975-06-24
IL46302A (en) 1978-09-29
IE42144B1 (en) 1980-06-18
LU71550A1 (fr) 1976-04-13
NO744621L (fr) 1975-07-21
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
ES451604A1 (es) 1977-12-16
DE2460537A1 (de) 1975-07-03
DK674674A (fr) 1975-09-08
FI65258B (fi) 1983-12-30
JPS50105689A (fr) 1975-08-20
FR2255076A1 (fr) 1975-07-18
SE7416195L (sv) 1975-09-22
HU172234B (hu) 1978-07-28
JPS5844675B2 (ja) 1983-10-04
CH617703A5 (en) 1980-06-13
FI371374A (fr) 1975-06-22
AU7673574A (en) 1976-06-24

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU465434B2 (fr)
AU450229B2 (fr)
FR2355849B1 (fr)
AR201229Q (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU476873B1 (fr)
AR201432A1 (fr)
AR200885A1 (fr)
AR200256A1 (fr)
AR195948A1 (fr)
AR193950A1 (fr)
AR197627A1 (fr)
AR196382A1 (fr)
AR195311A1 (fr)
AR210729A1 (fr)
AU447540B2 (fr)
AU477824B2 (fr)
AU1891376A (fr)
AR196123Q (fr)
AU5290373A (fr)

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee